NYSE · CIK 0001074828
USBC USBC, Inc.
Insider trading from SEC Form 4. Last filing 8 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Signals
Open-market buys and sells at USBC, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 33 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Kitty B Payne CFO, Treasurer, Secretary | JOther Option to Purchase Common Stockderivative | -1,342,500 | $0.00 | $0 | 447,500 | 8 d ago |
| Oct 1, 2026 | Daniel J Beck Chief Financial Officer | AGrant or award Option to Purchase Common Stockderivative | +2,500,000 | $0.00 | $0 | 2,500,000 | 8 d ago |
| Oct 1, 2026 | Kitty B Payne CFO, Treasurer, Secretary | JOther Option to Purchase Common Stockderivative | -1,470,000 | $0.00 | $0 | 490,000 | 8 d ago |
| Mar 18, 2026 | Linda Jenkinson director | DDisposition to issuer Option to Purchase Common Stockderivative | -10,000,000 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 18, 2026 | Kitty B Payne CFO, Treasurer, Secretary | DDisposition to issuer Option to Purchase Common Stockderivative | -3,750,000 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Mar 18, 2026 | Linda Jenkinson director | AGrant or award Option to Purchase Common Stockderivative | +10,000,000 | $0.00 | $0 | 10,000,000 | Mar 26, 2026 |
| Mar 18, 2026 | Kitty B Payne CFO, Treasurer, Secretary | AGrant or award Option to Purchase Common Stockderivative | +3,750,000 | $0.00 | $0 | 3,750,000 | Mar 26, 2026 |
| Oct 7, 2025 | Kirk Chapman Chief Operating Officer | DDisposition to issuer Option to Purchase Common Stockderivative | -7,140,000 | $0.00 | $0 | 0 | Oct 9, 2025 |
| Oct 7, 2025 | Linda Jenkinson director | DDisposition to issuer Option to Purchase Common Stockderivative | -4,760,000 | $0.00 | $0 | 0 | Oct 9, 2025 |
| Oct 7, 2025 | Kitty B Payne CFO, Treasurer, Secretary | DDisposition to issuer Option to Purchase Common Stockderivative | -1,790,000 | $0.00 | $0 | 0 | Oct 9, 2025 |
| Oct 7, 2025 | Kirk Chapman Chief Operating Officer | AGrant or award Option to Purchase Common Stockderivative | +7,140,000 | $0.00 | $0 | 7,140,000 | Oct 9, 2025 |
| Oct 7, 2025 | Linda Jenkinson director | AGrant or award Option to Purchase Common Stockderivative | +4,760,000 | $0.00 | $0 | 4,760,000 | Oct 9, 2025 |
| Oct 7, 2025 | Kitty B Payne CFO, Treasurer, Secretary | AGrant or award Option to Purchase Common Stockderivative | +1,790,000 | $0.00 | $0 | 1,790,000 | Oct 9, 2025 |
| Oct 7, 2025 | Kirk Chapman Chief Operating Officer | AGrant or award Option to Purchase Common Stockderivative | +7,860,000 | $0.00 | $0 | 15,000,000 | Oct 9, 2025 |
| Oct 7, 2025 | Kitty B Payne CFO, Treasurer, Secretary | AGrant or award Option to Purchase Common Stockderivative | +1,960,000 | $0.00 | $0 | 3,750,000 | Oct 9, 2025 |
| Oct 7, 2025 | Linda Jenkinson director | AGrant or award Option to Purchase Common Stockderivative | +5,240,000 | $0.00 | $0 | 10,000,000 | Oct 9, 2025 |
| Aug 6, 2025 | Kirk Chapman Chief Operating Officer | AGrant or award Option to Purchase Common Stockderivative | +7,140,000 | $0.00 | $0 | 7,140,000 | Aug 15, 2025 |
| Aug 6, 2025 | Linda Jenkinson director | AGrant or award Option to Purchase Common Stockderivative | +4,760,000 | $0.00 | $0 | 4,760,000 | Aug 15, 2025 |
| Aug 6, 2025 | Ronald P Erickson CEO | AGrant or award Common Stock | +335,000 | $0.00 | $0 | 472,202 | Aug 8, 2025 |
| Aug 6, 2025 | Kitty B Payne CFO, Treasurer, Secretary | AGrant or award Option to Purchase Common Stockderivative | +1,790,000 | $0.00 | $0 | 1,790,000 | Aug 8, 2025 |
| Jul 31, 2025 | Peter J Conley Chief Financial Officer | AGrant or award Common Stockindirect: Prestwick Associates LLC | +107,500 | $0.00 | $0 | 157,750 | Aug 8, 2025 |
| Aug 6, 2025 | Ronald P Erickson CEO | JOther Common Stockindirect: . | +2,000,000 | - | - | 2,000,000 | Aug 8, 2025 |
| Aug 6, 2025 | Ronald P Erickson CEO | JOther Series H Convertible Preferred Stockderivativeindirect: . | -16,916 | - | - | 0 | Aug 8, 2025 |
| Jun 2, 2025 | Ronald P Erickson CEO | JOther Series H Convertible Preferred Stockderivativeindirect: . | +16,916 | $1,184,066.00 | $20B | 16,916 | Jun 4, 2025 |
| May 5, 2025 | Peter J Conley Chief Financial Officer | AGrant or award Common Stockindirect: Prestwick Associates LLC | +50,000 | $0.44 | $22k | 50,250 | May 7, 2025 |
| May 5, 2025 | John E Cronin director | AGrant or award Common Stock | +25,000 | $0.44 | $11k | 25,404 | May 7, 2025 |
| May 5, 2025 | Ronald P Erickson CEO | AGrant or award Common Stock | +100,000 | $0.44 | $44k | 137,202 | May 7, 2025 |
| May 5, 2025 | Larry K Ellingson director | AGrant or award Common Stock | +25,000 | $0.44 | $11k | 25,404 | May 7, 2025 |
| May 5, 2025 | William Arthur Owens director | AGrant or award Common Stock | +25,000 | $0.44 | $11k | 48,692 | May 7, 2025 |
| May 5, 2025 | Jon Pepper director | AGrant or award Common Stock | +25,000 | $0.44 | $11k | 37,850 | May 7, 2025 |
| May 5, 2025 | Ichiro John Paul Takesako director | AGrant or award Common Stock | +25,000 | $0.44 | $11k | 28,875 | May 7, 2025 |
| May 5, 2025 | John E Cronin director | AGrant or award Common Stockindirect: ipCapital Group, Inc. | +25,000 | $0.44 | $11k | 25,000 | May 7, 2025 |
| Sep 11, 2024 | John E Cronin director | AGrant or award Option to Purchase Common Stockderivative | +1,000,000 | $0.00 | $0 | 1,000,000 | Oct 31, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Daniel J BeckChief Financial Officer
- Kirk ChapmanChief Operating Officer
- Peter J ConleyChief Financial Officer
- John E Cronindirector
- Ronald P EricksonCEO
- Larry K Ellingsondirector
- Linda Jenkinsondirector
- William Arthur Owensdirector
- Kitty B PayneCFO, Treasurer, Secretary
- Jon Pepperdirector
- Ichiro John Paul Takesakodirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.